SVP Liquidates All Direct Holdings in Supernus Pharmaceuticals

summarizeSummary

Supernus Pharmaceuticals' SVP of Commercial Operations, William Todd Horich, sold all of his direct shares, totaling $672,889, indicating a complete liquidation of his direct stake.

check_boxKey Events

• SVP Liquidates Direct Holdings

  William Todd Horich, SVP of Commercial Operations, disposed of all 8,877 shares of common stock through open market sales and 3,455 shares for tax withholding, resulting in zero direct shares held post-transaction.

• Significant Insider Selling

  The total value of shares sold by the SVP amounted to $672,889, comprising $483,797 from open market sales and $189,092 from tax-related dispositions.

• Contributes to Broader Insider Distribution

  This transaction follows a pattern of insider selling at Supernus Pharmaceuticals, with net insider sales of over $1.3 million from three active insiders in the last 90 days.

auto_awesomeAnalysis

William Todd Horich, SVP of Commercial Operations, has fully divested his direct holdings in Supernus Pharmaceuticals through open market sales and tax withholdings. While the total transaction value is modest relative to the company's market capitalization, a complete liquidation by a senior officer typically signals a lack of confidence in the company's future prospects. This transaction contributes to a broader pattern of insider distribution observed over the last 90 days.